Physician

Neurology

Dr. Wendy R. Galpern, MD

Wendy Galpern works in the field of Neurology. She attended University of Massachusetts Medical School. University of Massachusetts Medical School is ranked 49/12 in Research/PrimaryCare. Wendy Galpern is also a published MD. She has 28 publication published. The most recent publication is: In vivo PET imaging in rat of dopamine terminals reveals functional neural transplants.

Publications

Clinimetric testing of the comprehensive cervical dystonia rating scale.
Secured web-based video repository for multicenter studies.
A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit.
Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial.
Designing Clinical Trials for Dystonia.
The focal dystonias: Current views and challenges for future research.
Sham neurosurgical procedures in clinical trials for neurodegenerative Diseases: scientific and ethical considerations.
Ipratropium bromide spray as treatment for sialorrhea in Parkinson's Disease.
Management of impulse control disorders in Parkinson's Disease.
Screening potential therapies: lessons learned from new paradigms used in Parkinson Disease.
Interface between tauopathies and synucleinopathies: a tale of two proteins.
Cell-mediated delivery of neurotrophic factors and neuroprotection in the neostriatum and substantia nigra.
Predictors of cognitive outcomes in early Parkinson Disease patients: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.
A longitudinal program for biomarker development in Parkinson''s Disease: a feasibility study.
Neuroprotection: lessons from a spectrum of neurological disorders.
Coenzyme Q treatment of neurodegenerative Diseases of aging.
Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's Disease: functional recovery and graft morphology.
Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.
Effects of striatal excitotoxicity on huntingtin-like immunoreactivity.
Transplanted xenogeneic neural cells in neurodegenerative Disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal ...
Diagnostic criteria for psychosis in Parkinson's Disease: report of an NINDS, NIMH work group.
Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data.
NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington''s Disease.
Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration.
Embryonic stem cells differentiated in vitro as a novel source of cells for transplantation.
Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioral assessment.
In vivo PET imaging in rat of dopamine terminals reveals functional neural transplants.

Schools

University of Massachusetts Worcester Campus
Massachusetts General Hospital
Toronto Western Hospital

Conditions Treated

Gait Abnormality
Parkinson's Disease

Doctors Specialties

Neurology

Accepted Insurances

Education

Massachusetts General Hospital
University of Massachusetts Medical School

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Jeffrey P. Glass, MD This Doctor is OpenDoctor Recommended.
	Dr. Kaye E. Dowdy, MD
	Dr. Rahul H. Dave, MD
	Dr. Barbara P. Karp, MD This Doctor is OpenDoctor Recommended.
	Dr. Craig D. Blackstone, MD
	Dr. Carol A. Merchant, MD This Doctor is OpenDoctor Recommended.
	Dr. Nirjaleshwar K. Nikhar, MD This Doctor is OpenDoctor Recommended.
	Dr. Aviva Ellenstein, MD This Doctor is OpenDoctor Recommended.
	Dr. Henry Kaminski, MD This Doctor is OpenDoctor Recommended.
	Dr. Kevin R. Cannard, MD This Doctor is OpenDoctor Recommended.